Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

Lymphocyte subset characterization associated with persistent hepatitis C virus infection and subsequent progression of liver fibrosis.

Yoshida K, Ohishi W, Nakashima E, Fujiwara S, Akahoshi M, Kasagi F, Chayama K, Hakoda M, Kyoizumi S, Nakachi K, Hayashi T, Kusunoki Y.

Hum Immunol. 2011 Oct;72(10):821-6. doi: 10.1016/j.humimm.2011.05.029. Epub 2011 Jun 15.

PMID:
21712057
[PubMed - indexed for MEDLINE]
2.

Impaired CD4⁺ T cell stimulation of NK cell anti-fibrotic activity may contribute to accelerated liver fibrosis progression in HIV/HCV patients.

Glässner A, Eisenhardt M, Kokordelis P, Krämer B, Wolter F, Nischalke HD, Boesecke C, Sauerbruch T, Rockstroh JK, Spengler U, Nattermann J.

J Hepatol. 2013 Sep;59(3):427-33. doi: 10.1016/j.jhep.2013.04.029. Epub 2013 May 9.

PMID:
23665286
[PubMed - indexed for MEDLINE]
3.

Kinetics of intrahepatic hepatitis C virus (HCV)-specific CD4+ T cell responses in HCV and Schistosoma mansoni coinfection: relation to progression of liver fibrosis.

Kamal SM, Graham CS, He Q, Bianchi L, Tawil AA, Rasenack JW, Khalifa KA, Massoud MM, Koziel MJ.

J Infect Dis. 2004 Apr 1;189(7):1140-50. Epub 2004 Mar 12.

PMID:
15031780
[PubMed - indexed for MEDLINE]
Free Article
4.

Lack of optimal T-cell reactivity against the hepatitis C virus is associated with the development of fibrosis/cirrhosis during chronic hepatitis.

Sreenarasimhaiah J, Jaramillo A, Crippin J, Lisker-Melman M, Chapman WC, Mohanakumar T.

Hum Immunol. 2003 Feb;64(2):224-30.

PMID:
12559624
[PubMed - indexed for MEDLINE]
5.

Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure.

Golden-Mason L, Madrigal-Estebas L, McGrath E, Conroy MJ, Ryan EJ, Hegarty JE, O'Farrelly C, Doherty DG.

Gut. 2008 Aug;57(8):1121-8. doi: 10.1136/gut.2007.130963. Epub 2008 Mar 27.

PMID:
18372499
[PubMed - indexed for MEDLINE]
6.

Peripheral blood T, B, and NK cells in relation to histological hepatitis activity and fibrosis stage in chronic hepatitis C.

Panasiuk A, Prokopowicz D, Zak J, Wysocka J.

Hepatogastroenterology. 2003 Jan-Feb;50(49):178-82.

PMID:
12630018
[PubMed - indexed for MEDLINE]
7.

Natural killer p46High expression defines a natural killer cell subset that is potentially involved in control of hepatitis C virus replication and modulation of liver fibrosis.

Krämer B, Körner C, Kebschull M, Glässner A, Eisenhardt M, Nischalke HD, Alexander M, Sauerbruch T, Spengler U, Nattermann J.

Hepatology. 2012 Oct;56(4):1201-13. doi: 10.1002/hep.25804. Epub 2012 Aug 31.

PMID:
22532190
[PubMed - indexed for MEDLINE]
8.

Relationship of peripheral blood CD4-positive T cells to carcinogenesis in patients with HCV-related chronic hepatitis and liver cirrhosis.

Matsui T, Nagai H, Sumino Y, Miki K.

Cancer Chemother Pharmacol. 2008 Aug;62(3):401-6. Epub 2007 Oct 12.

PMID:
17932673
[PubMed - indexed for MEDLINE]
9.

Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.

de Arias AE, Haworth SE, Belli LS, Burra P, Pinzello G, Vangeli M, Minola E, Guido M, Boccagni P, De Feo TM, Torelli R, Cardillo M, Scalamogna M, Poli F.

Liver Transpl. 2009 Apr;15(4):390-9. doi: 10.1002/lt.21673.

PMID:
19326408
[PubMed - indexed for MEDLINE]
Free Article
10.

Immunopathogenesis in hepatitis C virus cirrhosis.

Spengler U, Nattermann J.

Clin Sci (Lond). 2007 Feb;112(3):141-55. Review.

PMID:
17199558
[PubMed - indexed for MEDLINE]
Free Article
11.

[Role of the Regulatory T lymphocytes in hepatitis C fibrosis progression].

Delhem N, Cottrez F, Carpentier A, Miroux C, Moralès O, François V, Groux H, Auriault C, Pancré V.

Bull Cancer. 2008 Nov;95(11):1029-38. doi: 10.1684/bdc.2008.0752. French.

PMID:
19036674
[PubMed - indexed for MEDLINE]
12.

Elevated numbers of Fc gamma RIIIA+ (CD16+) effector CD8 T cells with NK cell-like function in chronic hepatitis C virus infection.

Björkström NK, Gonzalez VD, Malmberg KJ, Falconer K, Alaeus A, Nowak G, Jorns C, Ericzon BG, Weiland O, Sandberg JK, Ljunggren HG.

J Immunol. 2008 Sep 15;181(6):4219-28.

PMID:
18768879
[PubMed - indexed for MEDLINE]
Free Article
13.

Liver-derived hepatitis C virus (HCV)-specific CD4(+) T cells recognize multiple HCV epitopes and produce interferon gamma.

Schirren CA, Jung MC, Gerlach JT, Worzfeld T, Baretton G, Mamin M, Hubert Gruener N, Houghton M, Pape GR.

Hepatology. 2000 Sep;32(3):597-603.

PMID:
10960455
[PubMed - indexed for MEDLINE]
14.

Interferon gamma-secreting HCV-specific CD8+ T cells in the liver of patients with chronic C hepatitis: relation to liver fibrosis--ANRS HC EP07 study.

Bonilla N, Barget N, Andrieu M, Roulot D, Letoumelin P, Grando V, Trinchet JC, Ganne-Carrié N, Beaugrand M, Deny P, Choppin J, Guillet J, Ziol M.

J Viral Hepat. 2006 Jul;13(7):474-81.

PMID:
16792541
[PubMed - indexed for MEDLINE]
15.

Lymphocyte subsets in renal allograft recipients with chronic hepatitis C virus infection.

Chan TM, Ho SK, Lai CL, Cheng IK, Lai KN.

Nephrol Dial Transplant. 1999 Mar;14(3):717-22.

PMID:
10193826
[PubMed - indexed for MEDLINE]
Free Article
16.

Decreased NK cell frequency in chronic hepatitis C does not affect ex vivo cytolytic killing.

Morishima C, Paschal DM, Wang CC, Yoshihara CS, Wood BL, Yeo AE, Emerson SS, Shuhart MC, Gretch DR.

Hepatology. 2006 Mar;43(3):573-80.

PMID:
16496327
[PubMed - indexed for MEDLINE]
17.

Oligoclonal CD8+ T-cell expansion in patients with chronic hepatitis C is associated with liver pathology and poor response to interferon-alpha therapy.

Manfras BJ, Weidenbach H, Beckh KH, Kern P, Möller P, Adler G, Mertens T, Boehm BO.

J Clin Immunol. 2004 May;24(3):258-71.

PMID:
15114056
[PubMed - indexed for MEDLINE]
18.

Detailed analysis of intrahepatic CD8 T cells in the normal and hepatitis C-infected liver reveals differences in specific populations of memory cells with distinct homing phenotypes.

Heydtmann M, Hardie D, Shields PL, Faint J, Buckley CD, Campbell JJ, Salmon M, Adams DH.

J Immunol. 2006 Jul 1;177(1):729-38.

PMID:
16785572
[PubMed - indexed for MEDLINE]
Free Article
19.

Intrahepatic lymphocyte phenotypes in hepatitis C virus infection: a comparison between cirrhotic and non-cirrhotic livers.

Bonacini M, Govindarajan S, Kohla M, Lai MM, Lindsay KL.

Minerva Gastroenterol Dietol. 2007 Mar;53(1):1-7.

PMID:
17415341
[PubMed - indexed for MEDLINE]
20.

The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study.

Di Martino V, Rufat P, Boyer N, Renard P, Degos F, Martinot-Peignoux M, Matheron S, Le Moing V, Vachon F, Degott C, Valla D, Marcellin P.

Hepatology. 2001 Dec;34(6):1193-9.

PMID:
11732009
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk